Pages that link to "Q41991738"
Jump to navigation
Jump to search
The following pages link to Long-acting injectable antipsychotics in first-episode schizophrenia (Q41991738):
Displaying 10 items.
- Two cases of long-acting paliperidone in adolescence (Q26777645) (← links)
- Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability - a review (Q28084899) (← links)
- The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal. (Q34418847) (← links)
- Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics (Q36467615) (← links)
- Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia (Q36981526) (← links)
- Clinical benefits and impact of early use of long-acting injectable antipsychotics for schizophrenia (Q38592404) (← links)
- Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia. (Q38851847) (← links)
- Psychiatrists' awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey (Q41201128) (← links)
- Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain (Q50867891) (← links)
- [Guidelines on long-acting injectable atypical antipsychotics for first-episode schizophrenia] (Q86423199) (← links)